CRUCELL APPOINTS AGENTS TO BOOST ASIAN MARKET POTENTIAL.Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CRXL), Leiden, The Netherlands, has entered into agreements with Pharma&Soft in South Korea and Biott in Japan to increase the licensing business for PER.C6 and Advac technology in Asia. Under the contracts, the two agencies shall help Crucell to contact and secure agreements with prospective Korean and Japanese PER.C6 and Advac licensees for the development and manufacturing of vaccines and gene therapy. They will also offer further support where useful. "The Asian market in general, and South Korea and Japan in particular, holds enormous potential for Crucell and its technology," commented Crucell's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Ronald Brus. "Crucell has already collaborated with South Korean and Japanese vaccine companies in the past and we believe that these newly forged relationships with Pharma&Soft and Biott will be a significant step in developing our vaccine and gene therapy business further in Asia." About Crucell Crucell N.V. is a biotechnology company focused on developing vaccines and antibodies that prevent and treat infectious diseases, including Ebola, influenza, malaria, West Nile virus West Nile virus, microorganism and the infection resulting from it, which typically produces no symptoms or a flulike condition. The virus is a flavivirus and is related to a number of viruses that cause encephalitis. and rabies. The company's development programs include collaborations with: sanofi pasteur for influenza vaccines; the U.S. National Institutes of Health for Ebola and malaria vaccines; and GlaxoSmithKline (GSK GSK GlaxoSmithKline plc (pharmaceutical company) GSK Glycogen Synthase Kinase GSK Gruppentraining Sozialer Kompetenzen (Germany) GSK Greenland Shark (FAO fish species code) ), Walter Reed Army Institute of Research This article is about the U.S. Army medical research institute (not the hospital). Otherwise, see Walter Reed (disambiguation). The Walter Reed Army Institute of Research (WRAIR) is the largest biomedical research facility administered by the U.S. and New York University New York University, mainly in New York City; coeducational; chartered 1831, opened 1832 as the Univ. of the City of New York, renamed 1896. It comprises 13 schools and colleges, maintaining 4 main centers (including the Medical Center) in the city, as well as the for a malaria vaccine. Crucell's products are based on its PER.C6 production technology. The company also licenses its PER.C6 technology to the biopharmaceutical industry. Licensees and partners include DSM 1. DSM - Data Structure Manager. An object-oriented language by J.E. Rumbaugh and M.E. Loomis of GE, similar to C++. It is used in implementation of CAD/CAE software. DSM is written in DSM and C and produces C as output. Biologics, GSK, Centocor/J&J and Merck & Co., Inc. Crucell is headquartered in Leiden, The Netherlands, and is listed on the Euronext and NASDAQ stock exchanges (ticker symbol CRXL). For more information, visit http://www.crucell.com. About Biott Biott Corporation is a joint company that combines ABLE Corporation and SC BioSciences Corporation. ABLE Corporation produces bioreactors and related commodities for microbe microbe /mi·crobe/ (mi´krob) a microorganism, especially a pathogenic one such as a bacterium, protozoan, or fungus.micro´bialmicro´bic mi·crobe n. and mammalian cell culture. SC BioSciences Corporation is a 100% subsidiary company of Sumitomo Corporation, which is one of the leading trading companies in Japan. As such, Biott possesses a superior sales network of Pharmaceutical and Biological companies, from basic research to mass production. For more information, visit http://www.able-biott.co.jp. About Pharma&Soft Pharma&Soft (PNS Peripheral nervous system (PNS) One of the two major divisions of the nervous system. PNS nerves link the central nervous system with sensory organs, muscles, blood vessels, and glands. ), located in South Korea, was founded in 1999 with the vision of becoming the first consulting company for unique services for biological products. The vision is based on the realization that R&D and regulatory processes for biological products differ from that of chemical drugs. PNS provides overall consultation and assistance on licensing in/out, R&D and regulatory affairs to the biology and biotechnology industry. With scientific and regulatory expertise, PNS provides customized solutions to the majority of biotechnology and pharmaceutical companies in Korea and currently extends services to cover overseas clients in Japan, Germany, India and Middle Eastern countries. For more information, visit http://www.pharmansoft.com. For more information about Crucell, visit http://www.crucell.com or call 212/926-1733. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion